CAMBRIDGE, Mass. (AP) _ InVivo Therapeutics Holdings Corp. (NVIV) on Friday reported a loss of $5.4 million in its fourth quarter.
The Cambridge, Massachusetts-based company said it had a loss of 17 cents per share. Losses, adjusted for non-recurring gains, came to 21 cents per share.
For the year, the company reported a loss of $23.4 million, or 76 cents per share, swinging to a loss in the period.
In the final minutes of trading on Friday, the company's shares hit $4. A year ago, they were trading at $8.78.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NVIV at https://www.zacks.com/ap/NVIV
Keywords: InVivo Therapeutics, Earnings Report